GeneFluidics develops and provides rapid diagnostic solutions for infectious diseases, focusing on hospital-acquired infections, pathogen identification, and antimicrobial susceptibility testing.

GeneFluidics

Aurora Diagnostics provides diagnostic services including COVID-19 testing, anatomic pathology, dermatopathology, molecular services, and hospital services. The company offers a research institute that supports bio-pharma and IVD companies with customizable services.

Aurora Diagnostics

ICPD is a laboratory services company that specializes in determining optimal dosing for antimicrobial drugs through research and testing to reduce the risk of developing antimicrobial resistance.

Metric
Company Name	GeneFluidics	Aurora Diagnostics	ICPD
Symbol
MSH ID	COM:GENEFLUIDICS	COM:AURORADX	COM:ICPD
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Diagnostics	Medical Diagnostics	Laboratory Services & Drug Development
Country	US	US	US
Stage
Employee Count
Website	genefluidics.com	auroradx.com	icpd.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:GENEFLUIDICS

GeneFluidics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue